Back to libraryGrowth Hormone

CJC-1295 DAC

Research profile · How we handle evidence

A long-lasting growth hormone booster that keeps your GH levels elevated for days. Often combined with Ipamorelin for what many consider the holy grail anti-aging stack. The DAC version is what makes it last - without it, you're looking at a 30-minute half-life like regular GHRH.

Evidence Score

60/100

Moderate confidence

Category

Growth Hormone

Therapeutic area

Standard Dose

1-2mg

Once weekly or twice weekly

Half-life

~168 hr

Plasma elimination

Route

SC

Subcutaneous

Safety Tier

2

Monitor closely

Overview

CJC-1295 DAC is like a slow-release GH booster that keeps working for nearly a full week. The DAC (Drug Affinity Complex) binds to your blood's albumin, protecting the peptide from rapid breakdown, so one injection keeps growth hormone elevated for 6-8 days. This makes it incredibly convenient, just 1-2 injections per week instead of daily pinning. It's most commonly stacked with Ipamorelin for the classic anti-aging and body recomposition protocol that clinics love. Start with 1mg twice weekly and watch for water retention or carpal tunnel symptoms as signs you need to dial back. Don't run it for more than 12-24 weeks without a break to avoid GH axis desensitization.

Mechanism of Action

CJC-1295 DAC is like a slow-release GH booster that keeps working for nearly a full week. The DAC (Drug Affinity Complex) binds to your blood's albumin, protecting the peptide from rapid breakdown, so one injection keeps growth hormone elevated for 6-8 days. This makes it incredibly convenient, just 1-2 injections per week instead of daily pinning. It's most commonly stacked with Ipamorelin for the classic anti-aging and body recomposition protocol that clinics love. Start with 1mg twice weekly and watch for water retention or carpal tunnel symptoms as signs you need to dial back. Don't run it for more than 12-24 weeks without a break to avoid GH axis desensitization.

GHRH Analogue With Drug Affinity Complex (DAC) For 6 8 Day Half LifeBinds Serum Albumin Via DAC Moiety For Prolonged GH Pulse AmplificationIncreases IGF 1 Levels By 1.5 2x Baseline When Combined With GHRPPreserves Natural Pulsatile GH Secretion Pattern Unlike Exogenous GH

pH & Mixing

10.6

Peptides reconstituted at very different pH levels can destabilize when combined in the same syringe, which lowers how much of the peptide your body actually absorbs. If you're unsure whether two peptides are close enough in pH, reconstitute and inject them separately.

A dedicated compatibility check between two specific peptides is coming to the Compare tool. This section covers this peptide's pH only.

Benefits

  • Long-acting - once or twice weekly dosing
  • Sustained growth hormone elevation
  • Increased IGF-1 production
  • Improved body composition and fat loss
  • Enhanced recovery and sleep quality
  • Synergizes excellently with GHRP peptides

Side Effects

  • Water retention at higher doses
  • Carpal tunnel syndrome (from IGF-1 elevation)
  • Numbness/tingling in extremities
  • Increased hunger
  • Fatigue
  • Potential GH desensitization with long-term use

Contraindications

  • Pregnant or breastfeeding women
  • Individuals under 18 years old
  • Those with known allergies to peptide components
  • Active cancer
  • Uncontrolled diabetes

Structure & Sequence

Verified structure

CJC-1295 DAC

Illustration uses the catalog amino acid sequence because no exact external registry match was confirmed.

Sequence-backed
C152H252N44O423,367.95 Da29 residues
Amino Acid Sequence
Y-D-Ala-DAIFTQSYRKVLGQLSARKLLQDILSR-NH2 (30aa, GHRH 1-29 analog with DAC moiety)
Molecular Weight
3,367.95 Da
Chemical Formula
C152H252N44O42
Reconstituted pH
10.6

Stack & Route Context

Stacks with

  • Ipamorelin
  • GHRP-6
  • GHRP-2
  • BPC-157

Administration

Subcutaneous

Research Status

Phase 2 clinical trials completed. Not FDA approved. Widely used in performance and anti-aging contexts.

Approval Status

Phase2

Sports Legal

Restricted

References

  1. 1

    CJC-1295, a long-acting GHRH analogue, increases GH and IGF-1 in healthy adults

    2006

This profile summarizes research literature for education only. It is not medical advice, and it does not diagnose, treat, or recommend a dose. Consult a qualified professional before changing a protocol.

Research-driven insights.Evidence-based decisions.